Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

When the seasonal flu strikes, most people expect the familiar lineup of fever, aches and congestion. But for many patients, dizziness emerges as an ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

For most people, the flu represents a few days of feeling miserable. Body aches, fever, cough, runny nose, sore throat, chills, and fatigue are common symptoms. Adults may call in sick to work to ...

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our ...

Typical flu symptoms include fever (usually 100-103 degrees Fahrenheit in adults and often even higher in children) and respiratory symptoms, such as cough, sore throat, runny or stuffy nose, as ...

A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers ...

Although effective influenza vaccines are available, many adults remain unvaccinated, and breakthrough cases still occur. Fortunately, we have antivirals that can reduce complications.

Similarly, early 2024-25 data from the U.S. shows that the vaccine was 41% to 55% effective against flu hospitalizations in adults and 63% to 78% effective against flu hospitalizations in children.

In adults 65 years and older, the group with the greatest risk of hospitalization and death, flu vaccination rates dropped from 52% in 2019-20 to 43% in 2024-25.

For both COVID-19 and flu, the symptoms do not start until about 1 to 4 days after infection, and symptoms seem to last longer for COVID-19. The only way to know what virus is causing an infection ...

In adults 65 years and older, the group with the greatest risk of hospitalization and death, flu vaccination rates dropped from 52% in 2019-20 to 43% in 2024-25.